Trademark: 79371028
Word
GCSA GLOBAL CLINICAL SITE ACCREDITATION
Status Date
Tuesday, June 18, 2024
Registration Number
7416560
Registration Date
Tuesday, June 18, 2024
Filing Date
Friday, January 6, 2023
Published for Opposition
Tuesday, April 2, 2024
41 Organisation of educational conferences, exhibitions and seminars for best practice sharing in the field of clinical trial site competency, practices and processes; information, advisory and consultancy services in relation all of the aforementioned services
35 Provision of business advice and assistance in the field of clinical trial site competency, practices and processes; gap analysis and process improvement, namely, business advice and management services, in the field of clinical trial site competency, practices and processes; human resource advice and management services in the field of clinical trial site competency, practices and processes; human resource process improvement services in the field of clinical trial site competency, practices and processes; information, advisory and consultancy services in relation to all of the aforementioned services
45 Reviewing standards and practices to assure compliance with laws and regulations in the field of clinical trial site competency, practices and processes; review and preparation of regulations, standards and compliance procedures being legal services in the field of clinical trial site competency, practices and processes; information, advisory and consultancy services in relation to all of the aforementioned services
42 Quality evaluation, checking, auditing and assurance services in the field of clinical research site competency, practices and processes to determine conformity with certification standards; quality checking in the field of clinical trial site competency, practices and processes; quality auditing in the field of clinical trial site competency, practices and processes; quality evaluation of clinical research sites to determine conformity with established accreditation standards; quality evaluation of clinical research sites to determine whether the organizations conform to an established accreditation standard of competency, practices and processes; clinical research and clinical trials quality evaluation services to determine conformity with established accreditation standards; information, advisory and consultancy services in relation to all the aforementioned services
The mark consists of four concentric curved lines in gradations of blue-green to the left of the wording "GCSA" | "GLOBAL CLINICAL SITE ACCREDITATION" in black. There is a black vertical line between the abbreviation and the wording.
The color(s) blue-green and black is/are claimed as a feature of the mark.
GLOBAL CLINICAL SITE ACCREDITATION
Jun 2, 2023
New Application Office Supplied Data Entered
Jun 6, 2023
Application Filing Receipt Mailed
Jun 1, 2023
Sn Assigned For Sect 66a Appl From Ib
Sep 29, 2023
Assigned To Examiner
Oct 26, 2023
Non-Final Action Written
Oct 27, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Oct 30, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Feb 13, 2024
Correspondence Received In Law Office
Feb 13, 2024
Teas/Email Correspondence Entered
Oct 30, 2023
Refusal Processed By Mpu
Nov 22, 2023
Refusal Processed By Ib
Feb 13, 2024
Teas Response To Office Action Received
Feb 21, 2024
Approved For Pub - Principal Register
Mar 13, 2024
Notification Of Notice Of Publication E-Mailed
Mar 27, 2024
Notification Of Possible Opposition Sent To Ib
Mar 27, 2024
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Apr 2, 2024
Published For Opposition
Apr 2, 2024
Official Gazette Publication Confirmation E-Mailed
Apr 16, 2024
Notification Processed By Ib
Jun 18, 2024
Registered-Principal Register
Jun 18, 2024
Notice Of Registration Confirmation Emailed
Trademark Alertz updated from USPTO on 2030-01-24
